PDF(Sci-hub)
Abstract：
Achilles tendon ruptures are common in the general population, especially among members of the older demographic occasionally active in sports. Operative treatments provide a lower incidence of rerupture than do nonoperative treatments, although surgical complications remain a concern. The use of a human acellular dermal matrix to augment Achilles tendon repair might reduce the incidence of complications. In the present case series, we describe the outcomes of 9 patients who underwent Achilles tendon repair with acellular dermal matrix augmentation. Functional outcomes were evaluated using the Foot Function Index-Revised long form, and the clinical results were recorded. After a mean average follow-up period of 14.4 (range 12.0 to 20.0) months, the mean Foot Function Index-Revised long form score was 33.0% ± 4.2%. No cases of rerupture or complications that required additional treatment occurred during the observation period. The outcomes we have presented support further evaluation beyond this case series for using a human acellular dermal matrix to augment Achilles tendon repairs.
摘要：
跟腱断裂在一般人群中很常见，尤其是在年龄较大的人群中偶尔活跃于体育运动中。与非手术治疗相比，手术治疗的再破裂发生率较低。尽管手术并发症仍然令人担忧。使用人脱细胞真皮基质来增强跟腱修复可能会降低并发症的发生率。在本案系列中，我们描述了9例接受跟腱修复和脱细胞真皮基质增强的患者的结局.使用脚功能指数修订的长表评估功能结果，并记录临床结果。平均随访时间为14.4个月（12.0至20.0个月），平均足部功能指数修订的长表评分为33.0%±4.2%。在观察期间，没有发生再破裂或需要额外治疗的并发症。我们提出的结果支持在此病例系列之外的进一步评估，以使用人脱细胞真皮基质来增强跟腱修复。
